Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine

Antiviral strategies in hepatitis C virus infection

(2012) Christoph Sarrazin et al.   JOURNAL OF HEPATOLOGY

Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus

(2012) E. Giang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The role of neutralizing antibodies in hepatitis C virus infection

(2011) V. C. Edwards et al.   JOURNAL OF GENERAL VIROLOGY

Clearance of Genotype 1b Hepatitis C Virus in Chimpanzees in the Presence of Vaccine-Induced E1-Neutralizing Antibodies

(2011) Babs E. Verstrepen et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus

(2011) Jean-Christophe Meunier et al.   JOURNAL OF INFECTIOUS DISEASES

Perspective: Test and treat this silent killer

(2011) Brian R. Edlin   NATURE

A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques

(2011) P. Garrone et al.   Science Translational Medicine

Characterization of the Envelope Glycoproteins Associated with Infectious Hepatitis C Virus

(2010) G. Vieyres et al.   JOURNAL OF VIROLOGY

Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt

(2010) F. D. Miller et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

(2010) Sharon E. Frey et al.   VACCINE

Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection

(2009) William O. Osburn et al.   GASTROENTEROLOGY

Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies

(2009) Romuald Patient et al.   New Biotechnology

Neutralizing Host Responses in Hepatitis C Virus Infection Target Viral Entry at Postbinding Steps and Membrane Fusion

(2008) Anita Haberstroh et al.   GASTROENTEROLOGY

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs

(2008) Judith M. Gottwein et al.   HEPATOLOGY

Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies

(2008) Z.-Y. Keck et al.   JOURNAL OF VIROLOGY

Hepatitis C vaccine: supply and demand

(2008) G Thomas Strickland et al.   LANCET INFECTIOUS DISEASES